Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - clostridium perfringens type d, strain 603 epsilon toxoid; clostridium septicum s1110/85 toxoid; clostridium tetani, strain 51123/91 toxoid; clostridium chauvoei strain no. 655; clostridium chauvoei strain no. 656; clostridium chauvoei strain no. 657; clostridium chauvoei strain no. 658; clostridium chauvoei strain no. 1048; formalin killed cells of mannheimia haemolytica serotypes a1; formalin killed cells of mannheimia haemolytica serotypes a2; formalin killed cells of mannheimia haemolytica serotypes a6; formalin killed cells of mannheimia haemolytica serotypes a7; formalin killed cells of mannheimia haemolytica serotypes a9; formalin killed cells of pasteurella trehalosi serotypes t3; formalin killed cells of pasteurella trehalosi serotypes t4; formalin killed cells of pasteurella trehalosi serotypes t10; formalin pasteurella trehalosi strain t15 (s1105/84) - suspension for injection - . - clostridium + pasteurella - sheep - immunological - inactivated vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - inactivated bovine respiratory syncytial virus, strain bio-24; inactivated bovine parainfluenza 3 virus, strain bio-23; inactivated mannheimia (pasteurella) haemolyica, a1 strain dsm 5283 - suspension for injection - . - inactivated viral and inactivated bacterial vaccines

Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - inactivated bovine respiratory syncytial virus, strain bio-24; inactivated bovine parainfluenza 3 virus, strain bio-23; inactivated mannheimia haemolytica serotype a1 strain dsm 5283; inactivated bovine viral diarrhoea virus, strain bio-25 - suspension for injection - . - inactivated viral and inactivated bacterial vaccines

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium sa-nv - bovine parainfluenza virus 3 (inactivated) ; bovine respiratory syncytial virus (inactivated) ; mannheimia haemolytica (inactivated) - suspension for injection - bovine respiratory syncytial virus (brsv); parainfluenza-3 virus; mannheimia haemolytica, inactivated - inactivated viral and inactivated bacterial vaccines - cattle

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium sa-nv - bovine parainfluenza virus 3 (inactivated) ; bovine respiratory syncytial virus (inactivated) ; mannheimia haemolytica (inactivated) ; bovine viral diarrhea virus (inactivated) - suspension for injection - bovine respiratory syncytial virus (brsv); parainfluenza-3 virus; bovine virus diarrhea (bvd); mannheimia haemolytica, inactivated - inactivated viral and inactivated bacterial vaccines - cattle

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios hipra s.a. - histophilus somni (inactivated) ; mannheimia haemolytica (inactivated, free of cells) > 2,8 elisa u/dose - emulsion for injection - histophilus somni, inactivated; mannheimia haemolytica, inactivated - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - cattle

Israel - English - Ministry of Health

beit-erez havat milatin ltd - gamithromycin - solution for injection - gamithromycin 150 mg/ml - * cattle: therapeutic and preventive treatment (metaphylaxis) of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni.the presence of the disease in the herd should be established before preventive treatment. * pigs (swine): treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida and haemophilus parasuis. * sheep:treatment of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus and fusobacterium necrophorum requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

virbac s.a. - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

ceva santé animale - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

vetoquinol - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.